Nick Muscato - Feb 23, 2023 Form 4 Insider Report for AMEDISYS INC (AMED)

Role
Chief Strategy Officer
Signature
Jennifer Guckert Griffin, pursuant to a power of attorney
Stock symbol
AMED
Transactions as of
Feb 23, 2023
Transactions value $
$0
Form type
4
Date filed
2/27/2023, 08:20 PM
Previous filing
Feb 22, 2023
Next filing
Jul 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMED Common Stock Award $0 +1.36K +9.64% $0.00 15.5K Feb 23, 2023 Direct F1
holding AMED Common Stock 213 Feb 23, 2023 By 401(k) Plan F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMED Stock Option (Right to Buy) Award $0 +2.88K $0.00 2.88K Feb 23, 2023 Common Stock 2.88K $91.77 Direct F3
transaction AMED Restricted Stock Unit (Performance-Based Vesting) Award $0 +2.73K $0.00 2.73K Feb 23, 2023 Common Stock 2.73K Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer awarded the Reporting Person 1,363 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 1/3 installments on each of February 20, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date.
F2 The information in this report is based on a plan statement dated as of December 31, 2022.
F3 The Stock Options are subject to time-based vesting conditions and will vest in equal, 1/3 installments on each of February 20, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date.
F4 The performance-based RSUs will cliff vest following a three-year performance period ending December 31, 2025 based on the Company's achievement of a pre-established performance measure for 2023, as modified by the Company's three-year total shareholder return percentile rank compared to a pre-established comparator group. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0% to 200% of the amount reported depending on the level of performance achieved.